A Second Look at Genetic Testing
The Carlat Psychiatry Report, Volume 17, Number 3, March 2019
https://www.thecarlatreport.com/newsletter-issue/tcprv17n3/
Issue Links: Learning Objectives | Editorial Information
Topics: GeneSight | Genetic Testing | Pharmacology
Chris Aiken, MD.
Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.
Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Genetic tests are marketed with a bold claim: that a handful of genes can predict medication response. AssureRx’s GeneSight is the most popular of these tests, and in 2015 we reviewed the evidence behind its panel. In short, it was lacking, but the company has just released new data that may move it a little closer to the mainstream.
You can't view details of this content, please login or buy subscription here